EP Patent

EP4349406A2 — Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole for use as a medicament

Assigned to Pfizer Inc · Expires 2024-04-10 · 2y expired

What this patent protects

The present invention relates to an oral dosage form comprising a crystalline form (Form 1) of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole, wherein said oral dosage form is a tablet or capsule.

USPTO Abstract

The present invention relates to an oral dosage form comprising a crystalline form (Form 1) of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole, wherein said oral dosage form is a tablet or capsule.

Drugs covered by this patent

Patent Metadata

Patent number
EP4349406A2
Jurisdiction
EP
Classification
—
Expires
2024-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.